rs371325199
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_017890.5(VPS13B):c.8465A>G(p.Tyr2822Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000316 in 1,614,052 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. Y2822Y) has been classified as Likely benign.
Frequency
Consequence
NM_017890.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VPS13B | NM_017890.5 | c.8465A>G | p.Tyr2822Cys | missense_variant | 46/62 | ENST00000358544.7 | |
VPS13B | NM_152564.5 | c.8390A>G | p.Tyr2797Cys | missense_variant | 46/62 | ENST00000357162.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VPS13B | ENST00000358544.7 | c.8465A>G | p.Tyr2822Cys | missense_variant | 46/62 | 1 | NM_017890.5 | ||
VPS13B | ENST00000357162.7 | c.8390A>G | p.Tyr2797Cys | missense_variant | 46/62 | 1 | NM_152564.5 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000591 AC: 9AN: 152188Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251094Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135682
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461746Hom.: 1 Cov.: 32 AF XY: 0.0000426 AC XY: 31AN XY: 727176
GnomAD4 genome ? AF: 0.0000591 AC: 9AN: 152306Hom.: 0 Cov.: 31 AF XY: 0.0000806 AC XY: 6AN XY: 74476
ClinVar
Submissions by phenotype
Cohen syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Oct 12, 2022 | This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 2822 of the VPS13B protein (p.Tyr2822Cys). This variant is present in population databases (rs371325199, gnomAD 0.01%). This missense change has been observed in individual(s) with Cohen syndrome (PMID: 16648375). ClinVar contains an entry for this variant (Variation ID: 528842). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt VPS13B protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 26, 2022 | The c.8465A>G (p.Y2822C) alteration is located in exon 46 (coding exon 45) of the VPS13B gene. This alteration results from a A to G substitution at nucleotide position 8465, causing the tyrosine (Y) at amino acid position 2822 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
VPS13B-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 27, 2024 | The VPS13B c.8390A>G variant is predicted to result in the amino acid substitution p.Tyr2797Cys. This variant has been reported in an individual with Cohen syndrome, but no additional studies were performed to help assess its pathogenicity (Seifert et al 2006. PubMed ID: 16648375). This variant is reported in 0.011% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at